Literature DB >> 6529872

Microvascular changes in progressive systemic sclerosis: immunohistochemical and ultrastructural study.

F Trotta, G Biagini, G Cenacchi, G Ballardini, C Varotti, B Passarini, S Garbisa, G Faccani, F B Bianchi, E Govoni.   

Abstract

Fifteen patients affected by Progressive Systemic Sclerosis have been studied. With immunofluorescence, specific antibodies against collagen type IV and laminin clearly outlined the microvessels, while endothelial cells showed a brilliant heavy fluorescence for vimentin antibodies. In the deep dermis, fibronectin proved to have increased. At electron microscopy, microvessels appeared with occluded lumina due to the presence of swollen endothelial cells. Endothelial cytoplasm was filled with intermediate filaments (vimentin type), generally condensed into peripherally located bundles or in perinuclear rings. The perivascular basal lamina was thickened and laminated. Although these changes do not demonstrate a specific pattern, representing a common step in several connective tissue disorders, the data tend to confirm a clear involvement of the microvasculature in Progressive Systemic Sclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6529872

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

Review 1.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 2.  Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.

Authors:  Mirko Manetti; Serena Guiducci; Lidia Ibba-Manneschi; Marco Matucci-Cerinic
Journal:  J Cell Mol Med       Date:  2010-01-30       Impact factor: 5.310

3.  Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

Authors:  Jo N Fleming; Richard A Nash; D O McLeod; David F Fiorentino; Howard M Shulman; M Kari Connolly; Jerry A Molitor; Gretchen Henstorf; Robert Lafyatis; David K Pritchard; Lawrence D Adams; Daniel E Furst; Stephen M Schwartz
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.